Team hopes pill can prevent accumulation of Alzheimer's-causing toxic proteins

Researchers from Baylor College of Medicine, Texas Children’s Hospital and Johns Hopkins University School of Medicine believe that a preventative pill for Alzheimer’s could be the solution in stopping this devastating disease.

The team worked to limit the amount of toxic proteins that accumulate in the brains of those who subsequently develop Alzheimer’s. In a study published in Neuron, the scientists reported some success in preventing proteins accumulation and the pathology they cause in animal models.

“When people started taking drugs that lower cholesterol, they lived longer and healthier lives rather than dying earlier of heart disease. Nobody has thought about Alzheimer’s disease in that light,” said senior study author Huda Zoghbi, MD, professor of molecular and human genetics and of pediatrics-neurology and developmental neuroscience at Baylor.

Read the full article by clicking the link below:

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

CMS finalized a significant policy change when it increased the Medicare payments hospitals receive for performing CCTA exams. What, exactly, does the update mean for cardiologists, billing specialists and other hospital employees?

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.